Alcon Inc.
NYSE:ALCMedical - Instruments & Supplies
+$0.61 today
- Market cap
- $36.15B
- Beta
- 0.70
- P/E (TTM)
- 38.7
- EPS (TTM)
- $1.67
- Dividend yield
- 0.55%
Volume 4.74M
Average 1.91M
ALC Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Alcon Inc.NYSE: ALC
Total Equity · Q3 FY2026 · quarter ended Sep 2026
Total equity broadly unchanged from a year ago
Total equity stood at $21.73B at the end of Q3 FY2026, down 1.5% from a year earlier and up 0.6% from the prior quarter. Over 3 fiscal years it compounded at +3.8% a year.
Context
- Total equity amounted to 69.3% of total assets at the end of Q3 FY2026, down 0.8 pp from a year earlier.
- Total equity increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps falling in the next quarterly balance sheet after a -1.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 22.04B USD
- Year-over-year change
- +2.2%
- 4-year CAGR
- +3.4%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 22.04B | +2.2% |
| FY2024 | 2024-12-31 | 21.55B | +4.5% |
| FY2023 | 2023-12-31 | 20.62B | +4.8% |
| FY2022 | 2022-12-31 | 19.68B | +2.2% |
| FY2021 | 2021-12-31 | 19.26B | — |
Total Equity vs competitors
How ALC compares with its peers on the latest reported figures
- ALC's Sep 2026 total equity of $21.73B is the highest of the 8 companies compared; the peer median is $352.37M.
- Its year-over-year change of -1.5% is the 5th highest of 8, against a peer median of -1.0%.
- Total equity amounts to 69.3% of total assets for ALC, versus a peer median of 65.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $21.73B | -1.5% | +3.8% | 69.3% | |
| Jul 2026 | $8.33B | -0.3% | +4.7% | 65.7% | |
| Jun 2026 | $6.44B | -1.0% | -2.8% | 46.5% | |
| Jun 2026 | $682.49M | -10.8% | +7.4% | 74.1% | |
| Apr 2026 | $352.37M | +0.7% | +0.8% | 78.1% | |
| Mar 2026 | $267.3M | -4.3% | +45.3% | 87.9% | |
| Mar 2026 | $53.9M | -30.6% | -26.4% | 49.1% | |
| Mar 2026 | $24.57M | +211.0% | — | 37.1% | |
| Peer median (excluding ALC) | $352.37M | -1.0% | +2.8% | 65.7% | |
Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.58B | 980M | 1.09B | 1.68B | 1.53B |
| Short-term Investments | 3M | 0 | 7M | 154M | 80M |
| Net Receivables | 1.59B | 1.99B | 1.89B | 2.08B | 1.94B |
| Inventory | 1.9B | 2.11B | 2.32B | 2.27B | 2.39B |
| Other Current Assets | 224M | 8M | 226M | 12M | 509M |
| Total Current Assets | 5.39B | 5.19B | 5.65B | 6.31B | 6.45B |
| Property, Plant & Equipment (Net) | 4.08B | 4.42B | 4.72B | 4.84B | 5.22B |
| Goodwill | 8.91B | 8.97B | 8.93B | 8.95B | 9.26B |
| Intangible Assets | 8.77B | 9.69B | 9.06B | 8.59B | 9.01B |
| Long-term Investments | 52M | 108M | 319M | 751M | 768M |
| Tax Assets | 409M | 411M | 443M | 421M | 0 |
| Other Non-current Assets | 399M | 422M | 496M | 495M | 855M |
| Total Non-current Assets | 22.61B | 24.02B | 23.97B | 24.04B | 25.11B |
| Total Assets | 28B | 29.21B | 29.61B | 30.35B | 31.56B |
| Account Payables | 903M | 861M | 811M | 773M | 926M |
| Short-term Debt | 107M | 97M | 48M | 101M | 575M |
| Tax Payables | 280M | 317M | 185M | 163M | 0 |
| Deferred Revenue | 108M | 89M | 77.97M | 72.84M | 0 |
| Other Current Liabilities | 586M | 907M | 627.03M | 539.16M | 751M |
| Total Current Liabilities | 2.47B | 2.74B | 2.4B | 2.28B | 3.05B |
| Long-term Debt | 3.97B | 4.54B | 4.68B | 4.54B | 4.16B |
| Deferred Tax Liabilities | 1.03B | 1.06B | 797M | 724M | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 32M | 86M | 0 |
| Other Non-current Liabilities | 940M | 786M | 752M | 739M | 1.88B |
| Total Non-current Liabilities | 6.27B | 6.75B | 6.59B | 6.52B | 6.47B |
| Total Liabilities | 8.74B | 9.53B | 8.99B | 8.79B | 9.52B |
| Common Stock | 20M | 20M | 20M | 20M | 20M |
| Retained Earnings | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 19.24B | 19.66B | 20.6B | 21.53B | 22.01B |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 1M |
| Total Equity | 19.26B | 19.68B | 20.62B | 21.55B | 22.04B |
| Total Debt | 4.48B | 5.07B | 5.14B | 5.14B | 5.25B |
| Net Debt | 2.9B | 4.09B | 4.04B | 3.45B | 3.72B |
Alcon Inc.
NYSE:ALC
Intrinsic Alpha fair value
Locked
Current Price
$75.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.